Nectar Lifesciences board approves INR 81 crore buyback at INR 27 per share

Corporate Actions View source PDF Explain this filing

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+16.4%Reaction day

₹18.00

prior close

₹20.60

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%+16.9% vs market

On the reaction day the stock moved 16.9 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.9

10m

-2.9

15m

-3.1

30m

-1.3

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

+16.4-0.5+16.9

Next day

+16.5-1.7+18.2

+13.8-4.0+17.8

+16.4-2.1+18.5

+16.8-2.7+19.5

+16.6-2.3+18.9

+16.9-1.5+18.4

15d

+11.6-1.8+13.4

+6.2+0.1+6.1

-23.7-3.3-20.3

-35.1-11.2-23.9

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nectar Lifesciences board approved a buyback of up to 3 crore shares (13.38 percent of paid-up capital) at INR 27 per share, worth INR 81 crore via tender offer route. Promoters will not participate. Record date is December 24, 2025. Mr. Sushil Kapoor also appointed as Director (Finance) for 3 years.

Likely market impact

Buyback at INR 27 per share offers exit for public shareholders since promoters are excluded. Positive capital return signal, may support the stock price.